Atlas Trials

Single Dose Cefepime Versus Cefuroxime Plus Metronidazole as a Prophylactic Antibiotic During Emergency Intrapartum Cesarean Section

Clinical trial NCT04009772 · UNKNOWN

Trial details

NCT number
NCT04009772
Sponsor
Assiut University
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Emergency Cesarean SectionInfection Wound
Start date
2019-07-01
Primary completion
2020-02-01
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.